Gilead Sciences | 应收帐款人



Trade Debtors 更改 日
AbbVie USD 12.48B 1.56B 2025-03
Agios Pharmaceuticals USD 4.99M 1.64M 2025-06
ALKERMES USD 356.33M 34.58M 2025-06
Alnylam Pharmaceuticals USD 567.11M 149.08M 2025-06
Amgen USD 8.7B 569M 2025-06
Biogen USD 2.08B 87.5M 2025-06
BioMarin Pharmaceutical USD 855.85M 116.68M 2025-06
Bristol-Myers Squibb USD 15.1B 515M 2025-06
Eli Lilly USD 17.21B 3.2B 2025-06
Gilead Sciences USD 4.78B 393M 2025-06
GlaxoSmithKline GBP 7.7B 196M 2025-06
Glaxosmithkline GBP 7.32B 542M 2024-12
Incyte USD 842.89M 19.76M 2025-06
J&J USD 16.02B 1.18B 2025-03
Merck USD 12.72B 1.14B 2025-06
Moderna USD 457M 151M 2025-06
Neurocrine Biosciences USD 595.7M 79.7M 2025-06
Novartis USD 9.18B 451M 2025-06
Pfizer USD 16.09B 1.35B 2025-06
PTC Therapeutics USD 196.13M 14.36M 2025-06
Regeneron Pharmaceuticals USD 5.61B 49M 2025-06
Sanofi 8.21B 7.76B 2025-06
Sarepta Therapeutics USD 609.6M 114.93M 2025-06
United Therapeutics USD 379.3M 57.3M 2025-06
Vertex Pharmaceuticals USD 1.89B 88.4M 2025-06


Gilead Sciences 应收帐款人 - 当前值，历史数据，预测，统计，图表和经济日历 - Aug 2025.